Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 4
2004 2
2005 4
2006 5
2008 2
2009 1
2010 4
2011 4
2012 11
2013 3
2014 4
2015 2
2016 4
2017 7
2018 4
2019 6
2020 2
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

66 results
Results by year
Filters applied: . Clear all
Page 1
Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and Cholangiocarcinoma.
Chaisaingmongkol J, Budhu A, Dang H, Rabibhadana S, Pupacdi B, Kwon SM, Forgues M, Pomyen Y, Bhudhisawasdi V, Lertprasertsuke N, Chotirosniramit A, Pairojkul C, Auewarakul CU, Sricharunrat T, Phornphutkul K, Sangrajrang S, Cam M, He P, Hewitt SM, Ylaya K, Wu X, Andersen JB, Thorgeirsson SS, Waterfall JJ, Zhu YJ, Walling J, Stevenson HS, Edelman D, Meltzer PS, Loffredo CA, Hama N, Shibata T, Wiltrout RH, Harris CC, Mahidol C, Ruchirawat M, Wang XW; TIGER-LC Consortium. Chaisaingmongkol J, et al. Among authors: bhudhisawasdi v. Cancer Cell. 2017 Jul 10;32(1):57-70.e3. doi: 10.1016/j.ccell.2017.05.009. Epub 2017 Jun 22. Cancer Cell. 2017. PMID: 28648284 Free PMC article.
Randomized, multicenter, open-label study of oxaliplatin plus fluorouracil/leucovorin versus doxorubicin as palliative chemotherapy in patients with advanced hepatocellular carcinoma from Asia.
Qin S, Bai Y, Lim HY, Thongprasert S, Chao Y, Fan J, Yang TS, Bhudhisawasdi V, Kang WK, Zhou Y, Lee JH, Sun Y. Qin S, et al. Among authors: bhudhisawasdi v. J Clin Oncol. 2013 Oct 1;31(28):3501-8. doi: 10.1200/JCO.2012.44.5643. Epub 2013 Aug 26. J Clin Oncol. 2013. PMID: 23980077 Clinical Trial.
Potential targeted therapy for liver fluke associated cholangiocarcinoma.
Vaeteewoottacharn K, Seubwai W, Bhudhisawasdi V, Okada S, Wongkham S. Vaeteewoottacharn K, et al. Among authors: bhudhisawasdi v. J Hepatobiliary Pancreat Sci. 2014 Jun;21(6):362-70. doi: 10.1002/jhbp.65. Epub 2014 Jan 10. J Hepatobiliary Pancreat Sci. 2014. PMID: 24408866 Review.
Urinary Metabolites Diagnostic and Prognostic of Intrahepatic Cholangiocarcinoma.
Haznadar M, Diehl CM, Parker AL, Krausz KW, Bowman ED, Rabibhadana S, Forgues M, Bhudhisawasdi V, Gonzalez FJ, Mahidol C, Budhu A, Wang XW, Ruchirawat M, Harris CC. Haznadar M, et al. Among authors: bhudhisawasdi v. Cancer Epidemiol Biomarkers Prev. 2019 Oct;28(10):1704-1711. doi: 10.1158/1055-9965.EPI-19-0453. Epub 2019 Jul 29. Cancer Epidemiol Biomarkers Prev. 2019. PMID: 31358519 Free PMC article.
Association between Pesticide Use and Cholangiocarcinoma.
Jeephet K, Kamsa-Ard S, Bhudhisawasdi V, Kamsa-Ard S, Luvira V, Luvira V. Jeephet K, et al. Among authors: bhudhisawasdi v. Asian Pac J Cancer Prev. 2016;17(8):3979-82. Asian Pac J Cancer Prev. 2016. PMID: 27644648 Free article.
Re-Rising of Total Bilirubin Level after Postoperative Day 3 (The V Pattern) Predicting Liver Failure and Survival of Patients who Underwent Hepatectomy for Cholangiocarcinoma.
Sawangkajohn W, Luvria V, Leeratanakachorn N, Tipwaratorn T, Theerakul S, Jarearnrat A, Titapun A, Srisuk T, Pugkhem A, Khuntikeo N, Bhudhisawasdi V, Kamsa-Ard S. Sawangkajohn W, et al. Among authors: bhudhisawasdi v. Asian Pac J Cancer Prev. 2020 Dec 1;21(12):3573-3578. doi: 10.31557/APJCP.2020.21.12.3573. Asian Pac J Cancer Prev. 2020. PMID: 33369454 Free PMC article.
Establishment of Highly Transplantable Cholangiocarcinoma Cell Lines from a Patient-Derived Xenograft Mouse Model.
Vaeteewoottacharn K, Pairojkul C, Kariya R, Muisuk K, Imtawil K, Chamgramol Y, Bhudhisawasdi V, Khuntikeo N, Pugkhem A, Saeseow OT, Silsirivanit A, Wongkham C, Wongkham S, Okada S. Vaeteewoottacharn K, et al. Among authors: bhudhisawasdi v. Cells. 2019 May 23;8(5):496. doi: 10.3390/cells8050496. Cells. 2019. PMID: 31126020 Free PMC article.
66 results